See the Glossary for more terms.
Concepts represent early planning stages for program announcements, request for applications, or solicitations for Council's input. If NIAID publishes an initiative from one of these concepts, we link to it below. To find initiatives, go to the Opportunities and Announcements portal.
NB: Council approval does not guarantee that a concept will become an initiative.
For the published program announcement identifying location of peer review, see the September 11, 2013, Guide announcement, Sustained Release of Antivirals for Treatment or Prevention of HIV (SRATP) (R01).
Request for Proposals
Contact: George Keane
Objective: Cure HIV infection.
Description: This initiative will provide funds and the laboratory infrastructure required to quantitate latently-infected cells in the blood of HIV-infected individuals, using the quantitative viral outgrowth assay (Q-VOA). The Q-VOA is the most accurate assay available today to measure latent virus in HIV-infected patients whose viral loads have been suppressed by antiretroviral therapy. This initiative aims to be a service resource to the HIV-eradication community by providing research laboratories with Q-VOA measurements of latent HIV.
For the published request for applications, see the July 1, 2013, Guide announcement, Innovative Assays to Quantify the Latent HIV Reservoir (R21).
Request for Applications
Contact: Alan Embry
Description: The goal of this initiative is to identify novel strategies to eliminate replication-competent HIV from infected individuals without necessitating reactivation of the latent provirus. This initiative will support research to:
Advances made in these areas will significantly accelerate the path to developing an effective strategy for curing HIV infection.
For the published request for applications, see the January 24, 2014, Guide announcement, Beyond HAART: Innovative Approaches to Cure HIV-1 (U19).
For the published request for applications, see the October 24, 2013, Guide announcement, Pilot Clinical Trials to Eliminate the Latent HIV Reservoir (U01).
For the published program announcement identifying location of peer review, see the December 18, 2013, Guide announcement, Centers for AIDS Research and Developmental Centers for AIDS Research (P30).
For the published request for proposals, see the March 6, 2014, solicitation, Clinical Pharmacology Quality Assurance Program.
Last Updated March 06, 2014
Last Reviewed July 01, 2013